Ellie Kincaid is an editor at Retraction Watch. Her work has appeared in STAT, The Wall Street Journal, Forbes, WebMD and Medscape. She has a B.A. in English from Washington University in St. Louis and an M.A. in journalism from New York University’s Science, Health and Environmental Reporting Program.
Ellie Kincaid
Editor
Retraction Watch
From this contributor
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read
Head of company that accredits autism service providers resigns after article retraction
The resignation follows reporting by Spectrum and Retraction Watch in October about nonexistent references in the retracted article.
Head of company that accredits autism service providers resigns after article retraction
By
Ellie Kincaid
29 November 2023 | 4 min read
Article defending private-equity involvement in autism services retracted
Nearly two-thirds of the article’s references appear to not exist.
Article defending private-equity involvement in autism services retracted
By
Ellie Kincaid, Retraction Watch
19 October 2023 | 5 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read